 |
 |
| A multi-focal intraocular lens (IOL) for cataract surgery patients, produced by Carl Zeiss Meditec. The technology is at the heart of a dispute between the German optics giant and VSY Biotechnology, a relatively young Dutch company looking to make a name for itself in ophthalmology. Credit: Zeiss. |
| © 2024 SPIE Europe |
|
